Angioedema, ACE inhibitor and COVID-19

SARS-CoV-2, the virus responsible for COVID-19, binds to the ACE2 receptors. ACE2 is thought to counterbalance ACE in the renin-angiotensin system. While presently it is advised that patients should continue to use ACE inhibitors or angiotensin receptor blockers, questions still remain as to whether...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Case Rep
Prif Awduron: Grewal, Ekjot, Sutarjono, Bayu, Mohammed, Ibbad
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2020
Pynciau:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7482445/
https://ncbi.nlm.nih.gov/pubmed/32912894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-237888
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg